Literature DB >> 7166447

Gallium-67 citrate as an aid to the diagnosis of infection in hip surgery.

F Crokaert, A Schoutens, J Wagner, J Ansay.   

Abstract

We have evaluated the use of Gallium-67 scans as an aid to the diagnosis of infection around the hip joint after operation. We performed 12 gallium-67 scintiscans on six patients with diaphyseal fractures of the femur or tibia reduced by external fixation, and 65 scintiscans on 60 hips after operation, which included 22 Moore's prosthesis, 31 total replacements, three nail-plates and four revisions of total replacements. We also scanned the healing surgical wounds in a further 11 patients. Simple fractures or osteotomies did not lead to abnormal uptake of 67Ga. Although some uptake in the scar was encountered the surgical wound did not complicate the interpretation of the scan. When assessing infection in the hip operations the rate of true-positive was 11/11, or 100%. The false-positive rate could not be assessed until after at least one year's follow-up. It was certainly less than 14% immediately after operation and less than 6% when the scan was performed three months after operation. Four patients were found to have a loose prosthesis but had a normal scintiscan, as had three patients presenting with post-operative pain. It appears that 67Ga is clinically an efficient means for early detection of infection about the operated hip, and is useful in the differential diagnosis of a painful hip after surgery.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7166447     DOI: 10.1007/bf00267726

Source DB:  PubMed          Journal:  Int Orthop        ISSN: 0341-2695            Impact factor:   3.075


  31 in total

1.  Results in patients with total hip replacement arthroplasty.

Authors:  W R Murray
Journal:  Clin Orthop Relat Res       Date:  1973-09       Impact factor: 4.176

2.  Interpretation of the 67 Ga photoscan.

Authors:  S M Larson; M S Milder; G S Johnston
Journal:  J Nucl Med       Date:  1973-04       Impact factor: 10.057

3.  The behaviour of tracer gallium-67 towards serum proteins.

Authors:  S W Gunasekera; L J King; P J Lavender
Journal:  Clin Chim Acta       Date:  1972-07       Impact factor: 3.786

4.  67 Ga-citrate for scanning experimental staphylococcal abscesses.

Authors:  D C Balair; M Carroll; E A Carr; F R Fekety
Journal:  J Nucl Med       Date:  1973-02       Impact factor: 10.057

5.  Experience with low-friction arthroplasty. A statistical review of early results and complications.

Authors:  N S Eftekhar; F E Stinchfield
Journal:  Clin Orthop Relat Res       Date:  1973-09       Impact factor: 4.176

6.  The nine and ten year results of the low-friction arthroplasty of the hip.

Authors:  J Charnley; Z Cupic
Journal:  Clin Orthop Relat Res       Date:  1973-09       Impact factor: 4.176

7.  85Sr radionuclide scintimetry in infected total hip arthroplasty.

Authors:  G C Bauer; L Lindberg; Y Naversten; L O Sjöstrand
Journal:  Acta Orthop Scand       Date:  1973

8.  The long-term results of low-friction arthroplasty of the hip performed as a primary intervention.

Authors:  J Charnley
Journal:  J Bone Joint Surg Br       Date:  1972-02

9.  Localization of Ga-67 in inflammations in the absence of circulating polymorphonuclear leukocytes.

Authors:  V M Dhawan; J J Sziklas; R P Spencer
Journal:  J Nucl Med       Date:  1978-03       Impact factor: 10.057

10.  Observations on the sequential use of 99mTc-phosphate complex and 67Ga imaging in osteomyelitis, cellulitis, and septic arthritis.

Authors:  R Losbona; L Rosenthall
Journal:  Radiology       Date:  1977-04       Impact factor: 11.105

View more
  2 in total

1.  [Diagnosis of infection in surgery of the locomotor system with Tc-99m-HMPAO leukocyte scintigraphy].

Authors:  K H Winker; P Reuland; S Weller; U Feine
Journal:  Langenbecks Arch Chir       Date:  1989

2.  Scintigraphy with Tc, Ga and In in painful total hip prostheses.

Authors:  M A Gómez-Luzuriaga; V Galán; J M Villar
Journal:  Int Orthop       Date:  1988       Impact factor: 3.075

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.